When writing a blockbuster movie script, screenplay writers are sure to include all the essential elements of a hit | The ...

The beleaguered genomic medicine biotech Sangamo has traveled a rough road lately, with recent years | Eli Lilly and Astellas ...

Insillico Medicine and SK Biopharmaceuticals have teamed up on an AI-enabled search for drug candidates targeting neuroimmune ...

Pfizer’s high-stakes bet on antibody-drug conjugates (ADCs) has hit a speed bump. | Pfizer announced Monday that sigvotatug ...

When Biogen announced the deal, the company said it expected a “significant portion” of Apellis staffers would stay on board. (No-Mad/iStock/Getty Images Plus) Biogen isn’t wasting any time ...

AbbVie has struck a deal to buy Apogee Therapeutics for $10.9 b | AbbVie has struck a deal to buy Apogee Therapeutics for $10 ...

Recently appointed Sanofi CEO Belén Garijo has stamped her mark on the organization, hiring former Roche executive Paulo ...

Osanni launched three years ago with a $27 million series A and has kept purposefully quiet ever since, founder and CEO ...

During her presentation, Moderna’s Das said the company proposed a “modified regulatory framework” during the FDA meeting.

Despite its massive $10.5 billion size and 12-drug scope, Pfizer’s oncology deal with Innovent Biologics took less than five ...

The FDA has sent an End of Enforcement notice to consumer wearable device company Whoop, putting a formal end to the agency’s ...

In another sign that the FDA is easing its stance toward rare disease drug candidates under new leadership, the agency will ...